In the News April 1, 2015

Investors’ Business Daily Quotes Jitty Malik on First FDA-approved Biosimilar

The Food and Drug Administration (FDA) has approved the first so-called biosimilar drug for use in the United States, paving the way for alternatives to an entire class of complex drugs.

“As the FDA becomes more comfortable … we’re going to see biosimilars get through a lot more easily,” predicted Jitty Malik, partner in Alston & Bird’s Intellectual Property Litigation Group who specializes in intellectual property and drug-approval issues. “The first one’s always the hardest to get through, because the FDA is more cautious – it’s uncharted territory.”
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement